Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-02-11

Clinical Trial Update: Safety and Immunogenicity of a Sabin Inactivated Poliovirus Vaccine (Phase Ib) [Phase 1, Phase 2]

View source ↗

Summary

Phase Ib/Phase II trial update assessing safety and immunogenicity of a Sabin inactivated poliovirus vaccine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sabin Inactivated Poliovirus Vaccine (inactivated poliovirus vaccine (Sabin strain))

Snippet

Sponsor: Jiangsu Province Centers for Disease Control and Prevention | Conditions: Polio | Phase 1, Phase 2 | Status: COMPLETED